Search - tctmd.com

Displaying 841 - 860 of 2114

Sort: Relevancy | Date

Presentation Live Valves 2019

Asymptomatic AS Live Valves-2019

Presenter: Maurice E. Sarano

December 10, 2019

Presentation Live Valves 2019

All Trileaflet AS (even low risk) Should be Treated with TAVI

Presenter: Vinod H. Thourani

December 10, 2019

News Daily News

Diastolic Dysfunction Does Not Negate Health Status Benefits of TAVR

Todd Neale

November 27, 2019

News Conference News PCR London Valves 2019

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

Michael O'Riordan

November 26, 2019

News Conference News PCR London Valves 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Michael O'Riordan

November 22, 2019

News Conference News PCR London Valves 2019

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Michael O'Riordan

November 20, 2019

News Conference News PCR London Valves 2019

Two Small Series Support Role for Cerebral Protection in TAVR

Michael O'Riordan

November 18, 2019

News Conference News AHA 2019

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Yael L. Maxwell

November 18, 2019

News Conference News AHA 2019

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

Yael L. Maxwell

November 16, 2019

Presentation Controversies and Advances 2019

Should TAVR Be Standard for Bicuspid Aortic Stenosis, Or Do We Need a Randomized Clinical Trial?

Presenter: Raj R. Makkar

November 15, 2019

Presentation Controversies and Advances 2019

Echo imaging in HFpEF

Presenter: Jeroen Bax

November 15, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Daily News

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Michael O'Riordan

November 06, 2019

News Industry News

Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe

November 06, 2019

News Daily News

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

L.A. McKeown

November 01, 2019

News Daily News

Gaps in Access to TAVR and SAVR: ‘Something Needs to Be Done’

L.A. McKeown

October 29, 2019

Presentation TCT Abstracts Posters 2019

Budget Impact of Mechanically Expanded Versus Self-Expanding Transcatheter Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis: A Medicare Perspective

Presenter: Stacey Amorosi

October 15, 2019

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Shelley Wood

October 08, 2019

Presentation TCT Abstracts Posters 2019

Predictors of short- and mid-term outcomes after TAVR in low-flow, lowgradient aortic stenosis

Presenter: Fernando Bernardi

September 29, 2019

Presentation TCT Abstracts Posters 2019

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

Presenter: Yuichi Ozaki

September 29, 2019

Advertisement

Asymptomatic AS Live Valves-2019

All Trileaflet AS (even low risk) Should be Treated with TAVI

Diastolic Dysfunction Does Not Negate Health Status Benefits of TAVR

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Two Small Series Support Role for Cerebral Protection in TAVR

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

Should TAVR Be Standard for Bicuspid Aortic Stenosis, Or Do We Need a Randomized Clinical Trial?

Echo imaging in HFpEF

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

Gaps in Access to TAVR and SAVR: ‘Something Needs to Be Done’

Budget Impact of Mechanically Expanded Versus Self-Expanding Transcatheter Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis: A Medicare Perspective

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Predictors of short- and mid-term outcomes after TAVR in low-flow, lowgradient aortic stenosis

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content